Paul Jin is a partner in the firm’s Antitrust and Competition practice. Mr. Jin’s antitrust expertise covers a broad spectrum of commercial transactions, including mergers and acquisitions, B2B collaborations, and pricing and supply arrangements. Mr. Jin regularly serves clients by assessing transaction-related antitrust risk, negotiating terms of agreements, and determining the applicability of merger clearance filing requirements in both U.S. and foreign jurisdictions. Mr. Jin routinely advocates on behalf of clients before the FTC, DOJ, and state regulators in connection with informal inquiries, Second Requests, third-party subpoenas, and conduct investigations. He also provides antitrust counseling on issues such as diligence and pre-closing conduct procedures, internal compliance programs, hiring and non-compete agreements, vendor agreements, and competitor collaboration guidelines. He has extensive knowledge of the Hart-Scott-Rodino (HSR) regime and has filed hundreds of notification forms with the FTC and DOJ for mergers, minority investments, asset acquisitions, and corrective fillings.

Prior to joining Goodwin in 2018, Mr. Jin was a partner in the antitrust practice at Wilson Sonsini Goodrich & Rosati, and previously practiced at Fried, Frank, Harris, Shriver & Jacobson LLP.





Select representations include:

  • Thoma Bravo in its acquisition of Nearmap for AUD $1.055 billion
  • Klaviyo in its product partnership with Shopify and on Shopify’s strategic investment in Klaviyo
  • Coalition in its $250 million Series F financing
  • BridgeBio Pharma in its exclusive license agreement with Bristol Myers Squibb for up to $905 million and sale of rare pediatric disease priority review voucher for $110 million
  • Slack Technologies, Inc. in its $27.7 billion acquisition by Salesforce
  • Virtusa Corporation in its $2 billion acquisition by Baring Private Equity Asia
  • Lucid Holdings in its $1.1 billion acquisition by Cint Group AB
  • Great Hill Partners in its acquisition of a controlling equity stake in Clearwave Parent, Inc. at an enterprise value of $300 million
  • The creation of Beth Israel Lahey Health
  • Twilio in its acquisition of SendGrid
  • The independent directors of Sprint Corporation in their merger with T-Mobile USA
  • PillPack, Inc. in its acquisition by Amazon
  • Qualtrics in its acquisition by SAP SE
  • AppNexus in its acquisition by AT&T
  • Moovit in its acquisition by Intel
  • iControl Networks in its acquisition by*
  • Microchip Technology in its acquisition of Atmel*
  • Pharmacyclics in its acquisition by AbbVie*
  • Cypress Semiconductor in its merger with Spansion*
  • Seagate Technology in its acquisition of Xyratex*
  • Google in various transactions, including its acquisition of Waze*

*Denotes experience prior to joining Goodwin.


Mr. Jin is recommended for Antitrust - Merger Control and Healthcare: Life Sciences by The Legal 500 United States (2019-2022).

In The News









J.D., 2003
Northwestern University School of Law
B.A., Economics, 2000
Duke University


U.S. Senate Committee on the Judiciary Subcommittee on Antitrust, Competition Policy, and Consumer Rights



District of Columbia
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique